Proximagen

Small molecules for neurodegenerative disorders, including Parkinson’s and Alzheimers.

placeLondon, England, United Kingdom calendar_todayFounded 2004 groups28 employees language proximagen.com

Registered entities

Innovation

175 patent families (35 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,661 times.

YearFilings
201334
201433
201528
201639
201728
201824
201918
202021
202117
20225
20234
20251

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon